24th Annual Meeting 2024 of the EURLSSG

← Back to all Meetings

Friday, December 13th, 2024 and (whole day)
Saturday, December 14th, 2024 (half day)

Location:
Auditorium "Pavillon", Technical University of Munich, Klinikum Rechts der Isar, Ismaninger Street 22, Munich, Germany

 

Registration:

  • Registration fee for members / applicants: 0,- €
  • Registration fee for non-members: 50,- € / students 20,- €

Deadline for registration is 31. October 2024.
If you want to register, please send an email to Sabine Panier, office@eurlssg.org
 

For members please note:
We would like to remind you that hotel and travel expenses can no longer be reimbursed.

 

Downloads:

  • Agenda Friday, 13th December and Saturday, 14th December (will follow - download)
  • Directions Pavillon (will follow - download)
  • Airport-Bus Schedule (will follow - download)
  • How to get to the Hotel Motel One, Deutsches Museum (will follow -    download)
  • Public car garages located near the hotel (will follow - download)


EURLSSG e.V. Session:

13th December 2024 - General Meeting of the EURLSSG   (EURLSSG members only)


Hotel for participants:

Motel One München-Deutsches Museum
Rablstraße 2
81669 München, Germany

phone: +49 (89) 444 555 8-0
muenchen-deutschesmuseum@motel-one.com

 

Dinner after the EURLSSG Meeting, 13th December 2024:

Restaurant "Zum Franziskaner"
Residenzstraße 9
80333 Munich

Phone: +49 89 231812-0
http://www.zum-franziskaner.de

Map of Munich:
http://www.stadtplan.net/bayern/reg-bez-oberbayern/munchen-landeshauptstadt/munchen


Presentations:

Friday 13th December 2024, 9:00 - 17:30 h


Welcome:

  • Literature Overview - Impact of RLS (Wolfgang Oertel, President, Germany)

Epidemiology

Chairperson: Claudia Trenkwalder, Germany

  • How to assess RLS in large population studies - Expert examination versus classification from questionnaires (Klaus Berger, Germany)

Genetics

Chairperson: Juliane Winkelmann, Germany

  • Update on the genetics of RLS (Barbara Schormair, Germany)

RLS and comorbidity

Chairpersons: Samson Khachatryan, Armenia and Giorgos Sakkas, Greece

  • RLS and other sleep disorders among young people of Georgia (Ketevan Mamasakhlisi, Georgia)
  • Restless legs syndrome in traumatic injury (Cristian Falup-Pecurariu, Romania)
  • Prevalance of RLS in patients with multiple sclerosis (Laura L. Triguero, Spain)
  • RLS in stroke - case control study (Iulia Murasan, Romania)
  • RLS as a surrogate of generalized dysautonomia (Olli Polo, Finland)
  • Effect of Restless Leges Syndrome medication on depression - prevalance in patients with RLS: A systemic review and meta-analysis (Yukiyoshi Sumi, Japan)
  • RLS and and peritoneal dialysis - update on a cohort study (Thomas MItterling, Austria)
  • RLS and the COVID pandemic (Markku Partinen, Finland)

Neurophysiology (and Imaging)

Chairperson: Federica Proini, Italy

  • Periodic leg movements (PLM) and large muscle group movements (LMM) during sleep along the lifespan in normal controls (Raffaele Ferri, Italy)
  • EEG for brain connectivity analysis in RLS - preliminary results (Doris Schuller-Götzburg, Austria)

Common projects of the EURLSSG

Chairperson: Wolfgang Oertel, Germany

  • Preview for Saturday - Summary slides

Case Reports

Chairperson: Lucia Muntean, Germany

  • High periodic leg movements persist after weight loss surgery and obstructive sleep apnea improvement (Galia Anguelova, The Netherlands)
  • Restless Back Syndrome (Evi Holzknecht, Austria)

Therapy

Chairpersons: Roselyne Rjisman, The Netherlands and Ambra Stefani, Austria

  • Physical exercise in restless legs syndrome (Evi Holzknecht, Austria)
  • Treatment response to Tramadol treatment in Japanese patients with restless legs syndrome and its associated factors (Yuichi Inoue, Japan)
  • Treatment of restless legs syndrome with Sativex (2,7 mg Delta-9-tetra-hydrocannabinol / 2,5 mg cannabidiol) (Laura L. Triguero, Spain)

Industrial Session

Chairpersons: Federica Provini, Italy and Wolfgang Oertel, Germany

  • Tonic motor activation (TOMAC) - a wearable neurostimulation therapy for Restless Legs Syndrome (Shri Raghunathan, Noctrix, USA)

Basic Science

Chairperson: Barbara Schormair, Germany

Dopamine receptors in restless legs syndrome and augmentation: An update on D3 and D1 receptor hypotheses (Stefan Clemens, USA)

EARLS

Chairpersons: Katharina Glanz, Germany and Stefan Clemens, USA

  • Making the invisible visible - 15 years EARLS RLS Patient Advocacy (Katharina Glanz, EARLS President, Germany)
  • How far have we succeded in our ambition to make primary care doctors updated on basic facts on RLS treatment (Sö¶ren Berg, Sweden)


Saturday 14th December 2024, 9:00 - 13:30 h


Welcome 
Wolfgang Oertel, President, Germany

Common Projects of the EURLSSG

Chairpersons: Federica Provini, Italy and Wolfgang Oertel, Germany

  • DATA BASE - RLS experts - physicians (Angelica Montini, Barbara Schormair, Wolfgang Oertel, Klaus Berger, Federica Provini and the EURLSSG)
  • DATA BASE - European RLS Patient-Registry (Wolfgang Oertel, Joke Jaarsma)

Chairpersons: Samson Khachatryan, Armenia and Giorgos Sakkas, Greece

  • USA-RLS Guidelines - versus European views - Shall EURLSSG endorse the USA-Recommendations? (Ambra Stefani and Samson Khachatryan)
  • Task Force European Grant application (Giorgos Sakkas and Stefan Clemens)
  • Task Force Website Content and Support (Burkhard Panier and Wolfgang Oertel)
  • Augmentation Rating Scale - Validation of translations?
  • Development of new rating scales / questionnaires (Comorbidity)?
  • Educational material - for and together with EAN and ESRS?
  • Others